Baturay et al., "Pyrene acts as a cocarcinogen with the carcinogens benzo[a]pyrene, .beta.-propiolactone and radiation in the induction of malignant transformation in cultured mouse fibroblasts; soybean extract containing the Bowman-Birk Inhibitor acts as an anticarcinogen," Cell Biology and Toxicology 1986, 2, 21-32. |
Birk et al., "Separation of a tribolium-protease inhibitor from soybeans on a calcium column," Biochim. Biophys. Acta 1963, 67, 326-328. |
Bowman, "Differentiation of Soy Bean Antitryptic Factors," Proc. Soc. Exptl. Med. 1946, 63, 547-550. |
Bradford, "A rapid and sensitive method for the quantitiation of microgram quantities of protein utilizing the principle of protein-dye binding," Anal. Biochem. 1976, 72, 248-254. |
Frenkel et al., "Chymotrypsin-specific protease inhibitors decrease H.sub.2 O.sub.2 formation by activated human polymorphonuclear leukocytes," Carcinogenesis 1987, 8(9), 1207-1212. |
Kennedy et al., Anticarcinogenesis and Radiation Protection, edited by Cerutti et al., Plenum Pub. Co. 1987, pp. 285-295. |
Messadi et al., "Inhibition of Oral Carcinogenesis by a Protease Inhibitor," JNCI 1986, 76, 447-452. |
Perlmann et al., "Proteolytic Enzymes," Methods in Enzymology 1970, 19, 860-861. |
St. Clair et al., "Suppression of Dimethylhydrazine-induced Carcinogenesis in Mice by Dietary Addition of the Bowman-Birk Protease Inhibitor," Cancer Res. 1990, 50, 580-586. |
Weed et al., "Protection against dimethylhydrazine-induced adenomatous tumors of the mouse colon by the dietary addition of an extract of soybeans containing the Bowman-Birk protease inhibitor," Carcinogenesis 1985, 6, 1239-1241. |
Yavelow et al., "Nanomolar concentrations of Bowman-Birk soybean protease inhibitor suppress x-ray-induced transformation in vitro," Proc. Natl. Acad. Sci. USA 1985, 82, 5395-5399. |
Yavelow et al., "Bowman-Birk soybean protease inhibitor as an anticarcinogen," Cancer Res. 1983, 43, 2454-2459. |